Top line data on the ATTRACT study
C21 shows promise against COVID-19 where other drugs have failed
Untangling the dualistic components of the RAS in PF the Yin and Yang
Patient insights to shape development of a dCBT for IPF patients
Vicore’s ATTRACT study shows promise for novel drug C21 against COVID-19 in hospitalised patients